Da Qian

601 total citations
36 papers, 366 citations indexed

About

Da Qian is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Da Qian has authored 36 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Da Qian's work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (3 papers). Da Qian is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (3 papers). Da Qian collaborates with scholars based in China and Taiwan. Da Qian's co-authors include Jinquan Cai, Xiangqi Meng, Shaoshan Hu, Pengfei Wu, Ziwei Li, Caijun Zha, Shihong Zhao, Lulu Li, Shan Mi and Xuli Meng and has published in prestigious journals such as Scientific Reports, Journal of Ethnopharmacology and BMC Genomics.

In The Last Decade

Da Qian

29 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Da Qian China 9 168 166 78 73 50 36 366
Kitty C. M. Castricum Netherlands 11 99 0.6× 178 1.1× 57 0.7× 81 1.1× 33 0.7× 19 318
Song Wei China 2 135 0.8× 225 1.4× 162 2.1× 57 0.8× 33 0.7× 2 411
Xiaoli Xie China 9 106 0.6× 188 1.1× 58 0.7× 81 1.1× 26 0.5× 19 329
Lorena Carmona‐Rodríguez Spain 9 154 0.9× 122 0.7× 82 1.1× 104 1.4× 30 0.6× 12 345
Xiaojie Gan China 12 99 0.6× 143 0.9× 87 1.1× 64 0.9× 20 0.4× 23 334
Weilong Chen China 9 127 0.8× 246 1.5× 118 1.5× 197 2.7× 53 1.1× 14 436
Yaqi Cheng China 9 58 0.3× 230 1.4× 131 1.7× 50 0.7× 43 0.9× 28 358
Sara Morlacchi Italy 7 314 1.9× 152 0.9× 45 0.6× 149 2.0× 22 0.4× 8 474
Shu Jia China 11 108 0.6× 168 1.0× 48 0.6× 112 1.5× 102 2.0× 22 386
Jin Gu Cho South Korea 5 78 0.5× 166 1.0× 85 1.1× 49 0.7× 51 1.0× 6 311

Countries citing papers authored by Da Qian

Since Specialization
Citations

This map shows the geographic impact of Da Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Qian more than expected).

Fields of papers citing papers by Da Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Da Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Qian. The network helps show where Da Qian may publish in the future.

Co-authorship network of co-authors of Da Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Da Qian. A scholar is included among the top collaborators of Da Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Da Qian. Da Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Qian, Da, et al.. (2025). Immunotherapeutic strategies targeting the PVR–TIGIT/CD96/CD226 signaling pathway in glioma treatment. Annals of Medicine. 57(1). 2588717–2588717. 1 indexed citations
6.
Tang, Hongchao, Danhong Wang, Da Qian, et al.. (2024). Xihuang pill suppresses breast cancer malignancy by inhibiting TGF-β signaling and acquires chemotherapy benefits. Journal of Ethnopharmacology. 337(Pt 3). 119000–119000. 4 indexed citations
7.
Qian, Da, Jie Qiu, Yadan Xu, et al.. (2024). Whole transcriptome sequencing indicated the Anti-tumor immunity of NLRP3 in breast cancer. Genomics. 116(5). 110930–110930.
8.
Qian, Da, et al.. (2024). Leveraging the intratumoral microbiota to treat human cancer: are engineered exosomes an effective strategy?. Journal of Translational Medicine. 22(1). 728–728. 8 indexed citations
10.
Huang, Mingyao, et al.. (2024). Methylation modification of non-histone proteins in breast cancer: An emerging targeted therapeutic strategy. Pharmacological Research. 208. 107354–107354. 1 indexed citations
12.
Wang, Danhong, Yadan Xu, Jie Qiu, et al.. (2023). Gut microbiome causal impacts on the prognosis of breast cancer: a Mendelian randomization study. BMC Genomics. 24(1). 497–497. 20 indexed citations
13.
Wang, Xinyu, Hao Chen, Dan Song, et al.. (2023). Using integrated analysis from multicentre studies to identify RNA methylation-related lncRNA risk stratification systems for glioma. Cancer Cell International. 23(1). 6 indexed citations
14.
Qian, Da, et al.. (2023). Expression and clinical significance of NCOA5 in epithelial ovarian cancer. Frontiers in Oncology. 13. 1117033–1117033. 1 indexed citations
15.
16.
Qian, Da, et al.. (2023). The association between frailty and osteoarthritis based on the NHANES and Mendelian randomization study. Archives of Medical Science. 19(5). 1545–1550. 10 indexed citations
17.
18.
Qian, Da, Yaoyao Xie, Mingyao Huang, & Jianfeng Gu. (2022). Tumor-derived exosomes in hypoxic microenvironment: release mechanism, biological function and clinical application. Journal of Cancer. 13(5). 1685–1694. 13 indexed citations
19.
Qian, Da, Qian Cheng, Ming Xu, et al.. (2022). Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis. Frontiers in Genetics. 13. 760514–760514. 8 indexed citations
20.
Qian, Da, Qinghui Zheng, Danping Wu, et al.. (2021). Integrated Analysis of ceRNA Network Reveals Prognostic and Metastasis Associated Biomarkers in Breast Cancer. Frontiers in Oncology. 11. 670138–670138. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026